
Overview
Leonel Kahn, MD is a board-certified radiation oncologist with Peachtree Radiation Oncology Services. He joined the group in 2018 and practices at Piedmont Kennesaw, Piedmont Atlanta Hospital, and Piedmont West. He practices general radiation oncology and has extensive experience with modern radiation oncology techniques (intensity modulated radiation therapy, image guided radiation therapy, and stereotactic body radiotherapy). He has a special interest in gastrointestinal, breast, and central nervous system malignancies. He has additional training in stereotactic radiosurgery (Gamma Knife and linear accelerator-based radiosurgery) for malignant and benign conditions.
Dr. Kahn is an enthusiastic and committed physician. His skill sets are particularly suited to bridge the gap between the systematic processes of treatment planning and delivery versus the warmhearted nature of caring for cancer patients. He is a critical thinker and enjoys the process of assimilating scientific evidence with patient-specific factors to determine the best treatment decision. His experience has refined his ability to make decisive choices in the face of complex cancer care. He also establishes deep bonds with his patients, grounded in compassion and empathy. He thrives on the demanding nature of the profession in terms of learning and updating his knowledge base as the field constantly evolves. Importantly, radiation oncology is a field in which he feels endlessly honored and humbled to work.
In addition to his clinical responsibilities, he is a voting member of the Piedmont Healthcare Institutional Review Board. He also has comprehensive training in clinical trial enrollment to national cooperative group protocols. He enjoys discussing potential clinical trials with patients, if it is in line with their wishes.
He attended Tulane University in New Orleans, Louisiana, where he received a Bachelor of Science in Neuroscience (Summa Cum Laude). He then earned his medical degree from Oregon Health and Science University in Portland, Oregon. For his graduate medical education, he performed an internship at Legacy Health System in Portland, Oregon and completed a radiation oncology residency at the University of California, Davis Comprehensive Cancer Center in Sacramento, California. He served as chief radiation oncology resident during his final year. Dr. Kahn was born in Louisiana, but raised in Eugene, Oregon. Walking his corgi dog and cooking are the two ways he spends most of his weekends. He is also very happily married.
Dr. Kahn is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. His top areas of expertise are Anal Cancer, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Pleuropulmonary Blastoma.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
187 Chastain Rd Nw, Ste 120, Kennesaw, GA 30144
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Piedmont Henry Hospital Radiation Oncology
Dr. Kim Vu Neisler graduated magna cum laude from Rhodes College with a Bachelor of Science in Biochemistry. She earned her medical degree from University of Tennessee and completed her residency in Radiation Oncology at the Medical University of South Carolina. Dr. Neisler, a board-certified radiation oncologist, has practiced in the Atlanta area as a member of Radiation Oncology Services since 2005. She currently serves as the Medical Director of the Piedmont Henry Radiation Oncology Center in Stockbridge, GA. Also, as Medical Director for the Piedmont Henry Oncology Program, Dr. Neisler works closely with the Oncology Director at Piedmont Henry Hospital to help coordinate the cancer program. She is also proud to serve as a member on the Piedmont Executive Cancer Committee, which was formed to implement changes and improvements to strengthen the entire Piedmont cancer program. Dr. Neisler practices primarily at Piedmont Henry Hospital. The community counts on her experience and expertise in the treatment of all types of cancers. She is well-versed in intensity-modulated radiation therapy (IMRT) and has special interests in breast cancer. Dr. Neisler works closely with a team of area surgeons, medical oncologists, and nurses to help coordinate comprehensive cancer care for all her patients. Dr. Neisler enjoys cooking and traveling to try new foods and therefore must also enjoy exercising. Dr. Neisler is rated as an Advanced provider by MediFind in the treatment of Breast Cancer in Men. Her top areas of expertise are Anal Cancer, Breast Cancer, Pleuropulmonary Blastoma, and Prostate Cancer.
Therapeutic Radiation Oncology, PC
"Sasha Wahab, MD, MA is a board-certified radiation oncologist who has been practicing in Atlanta since 2008. He earned his medical degree at Washington University in St. Louis, where he also attained a master's degree as part of the Doris Duke Clinical Research Fellowship. He stayed on for residency training at Washington University, one of the busiest and most respected radiation oncology programs in the country. He completed his undergraduate training at the University of Virginia, where he was awarded the honor of being an Echols Scholar.Dr. Wahab serves as Chief Clinical Officer for Radiation Oncology Services, one the largest radiation oncology practices in the metropolitan Atlanta area. Dr. Wahab helps lead a team of 10 radiation oncologists serving eight centers throughout the city. He has had a long affiliation with Piedmont Healthcare and is a core member of the Piedmont Radiation Oncology Steering Committee. He has previously served as Medical Director for the Southern Crescent Radiation Oncology Center and Cancer Committee Chair for the Southern Regional Medical Center. He has been an active participant and presenter in hundreds of multidisciplinary and specialty tumor conferences throughout his tenure in Atlanta.Dr. Wahab has accumulated vast experience in an array of advanced radiation oncology technologies including IMRT, IGRT, stereotactic ablative radiotherapy (SABR/SBRT) and Gamma Knife radiosurgery. He also has extensive experience in brachytherapy, including the treatment of breast and gynecologic malignancies with high-dose-rate Iridium-192. He started his career investigating the capacity of advanced imaging techniques to improve treatment delivery and has presented his research both nationally and internationally.Dr. Wahab has published in multiple peer reviewed oncology journals. ""I love being part of a large group with a well-deserved reputation. Since we cooperate and communicate effectively as a team, we see patients in a timely manner and seamlessly move each patient within our system so they receive treatment at the center closest to their home with the best equipment and expertise for their particular situation"". Dr. Wahab is rated as an Advanced provider by MediFind in the treatment of Breast Cancer in Men. His top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Prostate Cancer, and Familial Prostate Cancer.
Wellstar Medical Group LLC
William Thoms is a Radiation Oncologist in Hiram, Georgia. Dr. Thoms is rated as an Advanced provider by MediFind in the treatment of Breast Cancer in Men. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adenoid Cystic Carcinoma, and Acinic Cell Carcinoma of Salivary Glands. Dr. Thoms is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Anal CancerDr. Kahn isDistinguished. Learn about Anal Cancer.
- Posterior Fossa TumorDr. Kahn isDistinguished. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Kahn isDistinguished. Learn about Primitive Neuroectodermal Tumor (PNET).
- Advanced
- Adult Soft Tissue SarcomaDr. Kahn isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Alveolar Soft Part SarcomaDr. Kahn isAdvanced. Learn about Alveolar Soft Part Sarcoma.
- AngiosarcomaDr. Kahn isAdvanced. Learn about Angiosarcoma.
- AstrocytomaDr. Kahn isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Experienced
- Brain Stem CancerDr. Kahn isExperienced. Learn about Brain Stem Cancer.
- Breast Cancer in MenDr. Kahn isExperienced. Learn about Breast Cancer in Men.
- Cervical CancerDr. Kahn isExperienced. Learn about Cervical Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- EGFR Positive Lung CancerDr. Kahn isExperienced. Learn about EGFR Positive Lung Cancer.
